An acceptable incidence of infusion site reactions after subcutaneous bortezomib administration in the upper arm in Japanese patients with multiple myeloma.
作者信息
Ohgiya Daisuke, Tsuchiya Takahide, Suyama Takahiro, Watanabe Shigeki, Numata Hiroki, Tsuboi Kosuke, Sasao Tamotsu
机构信息
Department of Hematology, Ebina General Hospital, Ebina, Japan.
出版信息
Acta Haematol. 2015;133(1):29-30. doi: 10.1159/000362587. Epub 2014 Jul 1.
PMID:24993672
Abstract
摘要
相似文献
1
An acceptable incidence of infusion site reactions after subcutaneous bortezomib administration in the upper arm in Japanese patients with multiple myeloma.
Acta Haematol. 2015;133(1):29-30. doi: 10.1159/000362587. Epub 2014 Jul 1.
2
Subcutaneous bortezomib: a step towards optimised drug use.
Lancet Oncol. 2011 May;12(5):410-1. doi: 10.1016/S1470-2045(11)70098-5. Epub 2011 Apr 18.
3
Higher incidence of injection site reactions after subcutaneous bortezomib administration on the thigh compared with the abdomen.
Eur J Haematol. 2013 Feb;90(2):157-61. doi: 10.1111/ejh.12055. Epub 2013 Jan 9.
4
Injection site reaction after subcutaneous administration of bortezomib in Japanese patients with multiple myeloma.
Int J Hematol. 2012 Oct;96(4):525-7. doi: 10.1007/s12185-012-1167-x. Epub 2012 Sep 8.
5
Bortezomib subcutaneous injection in combination regimens for myeloma or systemic light-chain amyloidosis: a retrospective chart review of response rates and toxicity in newly diagnosed patients.
Clin Ther. 2013 Oct;35(10):1614-20. doi: 10.1016/j.clinthera.2013.08.015. Epub 2013 Sep 26.
6
Neurotoxicity of bortezomib therapy in multiple myeloma: a single-center experience and review of the literature.
Cancer. 2007 Sep 1;110(5):1042-9. doi: 10.1002/cncr.22921.
7
Bortezomib-induced peripheral neuropathy in patients with multiple myeloma.
Clin J Oncol Nurs. 2012 Feb;16(1):86-9. doi: 10.1188/12.CJON.86-89.
8
Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: a randomised, phase 3, non-inferiority study.
Lancet Oncol. 2011 May;12(5):431-40. doi: 10.1016/S1470-2045(11)70081-X. Epub 2011 Apr 18.
9
New data on subcutaneous bortezomib.
Acta Haematol. 2015;133(1):26-8. doi: 10.1159/000362639. Epub 2014 Jul 1.
10
[Effect of Velcade combined with Dexamethasone on multiple myeloma].
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2010 Aug;35(8):864-7. doi: 10.3969/j.issn.1672-7347.2010.08.015.
Zotero 插件